Production (Stage)
Pharvaris N.V.
PHVS
$16.78
$0.734.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.77M | -37.05M | -45.86M | -32.00M | -30.42M |
| Total Depreciation and Amortization | 110.80K | 97.00K | 47.90K | 73.90K | 72.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.58M | -4.48M | 10.76M | 272.70K | 2.27M |
| Change in Net Operating Assets | -2.41M | 4.18M | -1.52M | 1.86M | 1.77M |
| Cash from Operations | -40.49M | -37.26M | -36.57M | -29.80M | -26.31M |
| Capital Expenditure | -169.40K | -171.50K | -336.80K | -43.20K | -33.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -169.40K | -171.50K | -336.80K | -43.20K | -33.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -104.50K | -26.60K | -25.80K | -53.50K | -53.80K |
| Issuance of Common Stock | 29.10K | 592.70K | 1.02M | 443.00K | 189.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -1.00K | -66.10K | 659.00K |
| Cash from Financing | -79.40K | 603.50K | 1.09M | 348.10K | 863.10K |
| Foreign Exchange rate Adjustments | -5.81M | 10.75M | -6.38M | 2.83M | 627.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.55M | -26.08M | -42.20M | -26.66M | -24.85M |